Norovirus vaccine to be trialled in Scotland

Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.
Scientists in Pennsylvania have developed an experimental mRNA-based vaccine for C. diff bacteria, which often cause ...
Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...
A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides ...
Hello Health Rounds Readers! Today we report on a promising animal study of a mRNA vaccine that could one day prevent or ...
A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.
As one of the leading causes of acute gastroenteritis worldwide, NoV is associated with a substantial healthcare burden.
Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...
A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal ...
It primarily affects those who have excessively exposed themselves to the sun without proper precautions, and if not ...
A norovirus vaccine based on the mRNA technology that helped to defeat Covid will be trialled in the UK for the first time, ...